Trusted globally.
Harrison.ai Comprehensive Care is a breakthrough imaging AI solution for chest X-rays and non-contrast head CT that identifies 13 findings in under 90 seconds, reducing stress from chaotic worklists by surfacing emergent and incidental findings for review – all within the workflow you’re used to.
When everything is STAT, nothing is STAT.
Reduce stress from chaotic worklists. Let AI find the urgent needles in the non-urgent haystack.
Accelerate diagnosis of subtle chronic conditions.
Intuitive, powerful AI.
Multi-modal imaging AI.
Eight time-sensitive findings on non-contrast head CT and 5 findings on chest X-ray.
Seamless workflow.
The UI integrates seamlessly with your PACS & RIS, displaying a resizable, no-click overlay window with findings.
Customisable features.
Customisable thresholds for individual findings (to optimise for sensitivity / specificity), to tailor the workflow to your clinical setting or population.
“Implementing Harrison.ai Comprehensive Care marks a significant leap forward in our mission to provide the highest quality care to our patients. By helping our radiologists swiftly detect a range of critical conditions, this innovative technology allows the broader care team to safely achieve better outcomes and peace of mind for patients.”
Now FDA-cleared: acute infarct triage on non-contrast CT Brain.
Acute infarct is one of the most difficult findings to identify on non-contrast CT. Most ischemic stroke AI triage focuses on large vessel occlusion in one or two vascular territories. The rest go untriaged. Harrison.ai’s triage covers the full geography of the brain. Combined with seven other FDA-cleared CT Brain findings, Harrison.ai delivers the most comprehensive critical exam coverage on non-contrast CT Brain of any AI triage platform. Hemorrhagic and ischemic stroke in one integration.
- Triages actual brain tissue injury as ACA, MCA, PCA, cerebellar, basilar, and watershed infarcts, not just vessel occlusions.
- Up to 89.2% sensitivity on thin slices and 85.7% on thick slices with multiple operating points achieving 80% sensitivity/80% specificity on each.
- Validated against confirmed infarcts on advanced imaging, even when not guaranteed to be visible on non-contrast CT.
- Eligible for analysis on any non-contrast head CT, not just patients on a dedicated stroke protocol.
- Awarded FDA Breakthrough Device Designation.
Approved NTAP for obstructive hydrocephalus eligible for separate, additional hospital payment.
Time navigating between multiple platforms is time taken away from patient care. To mitigate this, our solutions are:
- Awarded Breakthrough Device Designation by the FDA.
- Available for thick and thin slices.
- Validated performance with sensitivity >97%, specificity 94%.
- Eligible for NTAP reimbursement from the Centres for Medicare & Medicaid (CMS) of up to $241.39 per patient.
Neurosurgeon in Orange, CA
“Patients with obstructive hydrocephalus can deteriorate rapidly if not promptly identified, evaluated, and treated. Harrison – OH will help care teams identify these patients faster, consult with their neurosurgeon, and reduce the chance that they suffer from severe complications.”
One solution. More clinical value.
Harrison.ai’s advanced imaging AI means you can benefit from powerful clinical impact and value across multiple use cases and healthcare settings.
Emergency and acute care
Teleradiology
Public hospitals
Private hospitals
Boosting the power of triage on the back of 254 clinical findings.
No shortcuts to quality.
Triage what others miss.
Triage the unexpected.
Enterprise-grade security.
Keep your company’s data secure and compliant with industry-leading security standards and certifications.
Discover how leading healthcare providers drive better patient care.
+1,000 sites across 4 continents use our AI solutions.
Of radiologists in Australia now have access to Harrison.ai solutions.
Of radiologists in Australia now have access to Harrison.ai Chest X-ray.
Hospitals in UK across 45+ NHS Trusts now use Harrison.ai solutions.
Disclaimers
Product images are stylised; may differ slightly from actual product UI. Harrison.ai Comprehensive Care is the marketing name for Annalise Critical Care AI. Harrison.ai Comprehensive Care is intended to assist clinicians with triage of radiological imaging studies and provide notification of suspected findings. For detailed information regarding indications for use, contraindications, and warnings, please consult the user guide prior to use.
The information on this website is intended exclusively for the use of healthcare professionals. The products displayed on this website are not available for purchase by the general public and are intended for professional use only.
The content of this website, including product and features, may not be approved or available for use in your specific region or country.